LISW Therapy With Umbilical Cord Derived Stem Cells for Diabetic Erectile Dysfunction

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058116

Enrollment

Unknown

Registered

2022-03-30

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Interventions

2:Umbilical Cord Derived Stem Cells

1:Saline

Eligibility

Sex/Gender

Male

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with erectile dysfunction diagnosed clinically from 20 to 60 years old; 2. diabetes ED patients with poor PDE5i treatment effect; 3. Patients who need treatment subjectively and can cooperate with follow-up and treatment; 4. No serious chronic disease.

Exclusion criteria

Exclusion criteria: 1. Age60 years; 2. Non diabetes ED; 3. History of acute and chronic diseases, major trauma and surgery; 4. History of unstable myocardial infarction and cerebral infarction; 5. Have a history of cardiogenic shock, severe heart failure, severe ventricular arrhythmia, etc; 6. There are serious diseases such as malignant tumors, chronic liver and kidney diseases, etc.

Design outcomes

Primary

Measure	Time frame
IIRF-5;EHS;NPTR;	—

Countries

China

Contacts

Public ContactLu Mujun

Shanghai Jiading Central Hospital

lumujun@163.com+86 13020156427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026